Sipai Health Technology Co Ltd

HKSE:00314 (China)  
HK$ 6.02 (+1.01%) May 27
At Loss
P/B:
2.58
Market Cap:
HK$ 4.58B ($ 587.20M)
Enterprise V:
HK$ 3.37B ($ 432.14M)
Volume:
161.20K
Avg Vol (2M):
647.25K
Also Trade In:
Volume:
161.20K
At Loss
Avg Vol (2M):
647.25K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sipai Health Technology Co Ltd ( HKSE:00314 ) from 2022 to May 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sipai Health Technology stock (HKSE:00314) PE ratio as of May 27 2024 is 0. More Details

Sipai Health Technology Co Ltd (HKSE:00314) PE Ratio (TTM) Chart

To

Sipai Health Technology Co Ltd (HKSE:00314) PE Ratio (TTM) Historical Data

Total 348
  • 1
  • 2
  • 3
  • 4
Sipai Health Technology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-28 At Loss 2024-03-19 At Loss
2024-05-27 At Loss 2024-03-18 At Loss
2024-05-24 At Loss 2024-03-15 At Loss
2024-05-23 At Loss 2024-03-14 At Loss
2024-05-22 At Loss 2024-03-13 At Loss
2024-05-21 At Loss 2024-03-12 At Loss
2024-05-20 At Loss 2024-03-11 At Loss
2024-05-17 At Loss 2024-03-08 At Loss
2024-05-16 At Loss 2024-03-07 At Loss
2024-05-14 At Loss 2024-03-06 At Loss
2024-05-13 At Loss 2024-03-05 At Loss
2024-05-10 At Loss 2024-03-04 At Loss
2024-05-09 At Loss 2024-03-01 At Loss
2024-05-08 At Loss 2024-02-29 At Loss
2024-05-07 At Loss 2024-02-28 At Loss
2024-05-06 At Loss 2024-02-27 At Loss
2024-05-03 At Loss 2024-02-26 At Loss
2024-05-02 At Loss 2024-02-23 At Loss
2024-04-30 At Loss 2024-02-22 At Loss
2024-04-29 At Loss 2024-02-21 At Loss
2024-04-26 At Loss 2024-02-20 At Loss
2024-04-25 At Loss 2024-02-19 At Loss
2024-04-24 At Loss 2024-02-16 At Loss
2024-04-23 At Loss 2024-02-15 At Loss
2024-04-22 At Loss 2024-02-14 At Loss
2024-04-19 At Loss 2024-02-09 At Loss
2024-04-18 At Loss 2024-02-08 At Loss
2024-04-17 At Loss 2024-02-07 At Loss
2024-04-16 At Loss 2024-02-06 At Loss
2024-04-15 At Loss 2024-02-05 At Loss
2024-04-12 At Loss 2024-02-02 At Loss
2024-04-11 At Loss 2024-02-01 At Loss
2024-04-10 At Loss 2024-01-31 At Loss
2024-04-09 At Loss 2024-01-30 At Loss
2024-04-08 At Loss 2024-01-29 At Loss
2024-04-05 At Loss 2024-01-26 At Loss
2024-04-03 At Loss 2024-01-25 At Loss
2024-04-02 At Loss 2024-01-24 At Loss
2024-03-28 At Loss 2024-01-23 At Loss
2024-03-27 At Loss 2024-01-22 At Loss
2024-03-26 At Loss 2024-01-19 At Loss
2024-03-25 At Loss 2024-01-18 At Loss
2024-03-22 At Loss 2024-01-17 At Loss
2024-03-21 At Loss 2024-01-16 At Loss
2024-03-20 At Loss 2024-01-15 At Loss

Sipai Health Technology Co Ltd (HKSE:00314) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.